論文・技術情報追加のお知らせ

①Evaluation of adverse events of bamlanivimab, bamlanivimab/etesevimab used for COVID-19 based on FAERS database.

COVID-19に使用されたバムラニビマブ・エテセビマブの有害事象ファーマコビジランス研究

対象DB：FAERS

②A pharmacovigilance analysis of FDA Adverse Event Reporting System events for romosozumab.

ロモソズマブの有害事象ファーマコビジランス研究

対象DB：FAERS

③Safety of Glucagon-Like Peptide-1 Receptor Agonists: A Real-World Study Based on the US FDA Adverse Event Reporting System Database.

GLP-1RAのベイズ分析によるシグナルを用いた安全性調査研究

対象DB：FAERS

④A tree-based scan statistic for zero-inflated count data in post-market drug safety surveillance.

ツリーベースのスキャン統計によるシグナル検出開発と検証

対象DB：KAERS

⑤Booster dose of COVID-19 mRNA vaccine does not increase risks of myocarditis and pericarditis compared with primary vaccination: New insights from the vaccine adverse event reporting system.

COVID-19 mRNAワクチンのブースター投与による心筋炎・心膜炎のリスク評価研究

対象DB：VAERS

⑥Urinary incontinence as a possible signal of neuromuscular toxicity during immune checkpoint inhibitor treatment: Case report and retrospective pharmacovigilance study.

免疫チェックポイント阻害剤治療中の神経筋毒性シグナルと考えられる尿失禁調査研究

対象DB：FAERS